AIDS
Researchers use gene-editing tool CRISPR to cure mice of HIV
July 3, 2019Research and Development AIDS, HIV, Nature Communications, crispr, mice, pharma
American scientists have been able to combine a new form of antiretroviral therapy (ART) with gene editing tool CRISPR/Cas9 to …
Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says
May 15, 2019Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs
Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …
Health Secretary pledges to end transmission of HIV in England by 2030
January 31, 2019Medical Communications, Research and Development 2030, AIDS, England, HIV, UN, health
Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by …
J&J announce promising Phase 1/2a results for HIV vaccine
October 23, 2018Manufacturing and Production AIDS, HIV, J&J, JJ, Vaccine, infectious diseases
The world may be one step closer to discovering a preventative vaccine for HIV following American multinational Johnson & Johnson’s …
Researchers launch Phase 1 trial of HIV vaccine
October 18, 2018Research and Development AIDS, HIV, Vaccine, infection, resdearch
Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …
HIV on the rise among straight men in Australia
September 24, 2018Medical Communications, Sales and Marketing AIDS, Aboriginal, Australia, HIV, Kirby Institute
The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report …
Ibalisumab effective in in treating multidrug resistant HIV
August 16, 2018Research and Development AIDS, HIV, multidrug resistance, phase 3
The monoclonal antibody Ibalizumab has shown significant antiviral activity against multidrug resistant HIV infections, according to the results of a …
Those at risk of HIV to be offered PrEP drugs in England and Northern Ireland
July 27, 2018Medical Communications AIDS, England, HIV, PrEP, Terrence Higgins Trust
Those at risk of contracting HIV will now be offered PrEP drugs in England and Northern Ireland through a programme …
India, Sweden and The Netherlands form HIV/AIDS research partnership
May 22, 2018Manufacturing and Production, Research and Development AIDS, HIV, India, Sweden, The Netherlands, pharma
A first-of-its-kind collaboration has been announced by the governments of India, Sweden and The Netherlands with the goal of advancing …
AIDS charity lambasts “ethically challenged” Gilead over price hikes
January 11, 2018Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical
The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …
The global HIV/AIDS movement
November 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AIDS, HIV, International HIV/AIDS Alliance
Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …
FDA approves first-ever two-drug HIV regimen, GSK’s Juluca
November 22, 2017Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma
GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …
Monthly injectable HIV treatment proves as effective as traditional daily pill regimen
July 24, 2017Research and Development, Sales and Marketing AIDS, HIV, Janssen, ViiV Healthcare, biotech, drugs, pharma, pharmaceuticals
New early trial data suggests that current daily HIV pill regimens could be replaced with injections which slowly release medication …
Inovio posts “exceptional” results for HIV vaccine
May 25, 2017Research and Development AIDS, HIV, HIV vaccine, Vaccine
Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …
Terrence Higgins Trust announces new CEO
January 6, 2016Medical Communications AIDS, HIV, Terrance Higgins Trust
Leading UK-based HIV and sexual health charity The Terrence Higgins Trust has announced the appointment of Ian Green as the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
